CoChat

Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis

Open access
Lloyd, J.O., Hill, B., Murphy, M., Al-Kaisy, A., Andreou, A. P., Lambru, G. · 2022 · The Journal of Headache and Pain

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Background: Initial evidence have shown the short-term efficacy of sTMS in the acute and preventive treatment of migraine. It is unknown whether this treatment approach in the long-term is effective and well tolerated in difficult-to-treat migraine. Methods: This is a prospective, single centre, open-label, real-world analysis conducted in difficult-to-treat patients with high-frequency episodic migraine (HFEM) and chronic migraine (CM) with and without medication overuse headache (MOH), who were exposed to sTMS therapy. Patients responding to a three-month sTMS treatment, continued the treatment and were assessed again at month 12. The cut-off outcome for treatment continuation was reduction in the monthly moderate to severe headache days (MHD) of at least 30% (headache frequency responders) and/or a ≥ 4-point reduction in headache disability using the Headache Impact test-6 (HIT-6) (headache disability responders). Results: One hundred fifty-three patients were included in the analysis (F:M = 126:27, median age 43, IQR 32.3–56.8). At month 3, 93 out of 153 patients (60%) were responders to treatment. Compared to baseline, the median reduction in monthly headache days (MHD) for all patients at month 3 was 5.0 days, from 18.0 (IQR: 12.0–26.0) to 13.0 days (IQR: 5.75–24.0) (P = 0.002,r = − 0.29) and the median reduction in monthly migraine days (MMD) was 4.0 days, from 13.0 (IQR: 8.75–22.0) to 9.0 (IQR: 4.0–15.25) (P = 0.002,r = − 0.29). Sixty-nine out of 153 patients (45%) reported a sustained response to sTMS treatment at month 12. The percentage of patients with MOH was reduced from 52% (N = 79/153) at baseline to 19% (N = 29/153) at month 3, to 8% (N = 7/87) at month 12. There was an overall median 4-point reduction in HIT-6 score, from 66 (IQR: 64–69) at baseline to 62 at month 3 (IQR: 56–65) (P < 0.001,r = − 0.51). A total of 35 mild/moderate adverse events were reported by 23 patients (15%). One patient stopped sTMS treatment due to scalp sensitivity. Conclusions: This open label analysis suggests that sTMS may be an effective, well-tolerated treatment option for the long-term prevention of difficult-to-treat CM and HFEM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s10194-022-01428-6

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Spring TMS optimal placement and coil locations
Fig. 1 Spring TMS optimal placement and coil locationsCC BY · PubMed Central
Fig. 2 Audit flowchart
Fig. 2 Audit flowchartCC BY · PubMed Central
Fig. 3 Effectiveness outcomes of patients continuing to use single-pulse transcranial magnetic stimulation at baseline and at 3 and 12 months
Fig. 3 Effectiveness outcomes of patients continuing to use single-pulse transcranial magnetic stimulation at baseline and at 3 and 12 monthsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. Lambru G, Lanteri-Minet M (2019) Neuromodulation in headache and facial pain management: principles. Springer Nature, Rationale and Clinical Data
  2. Ltd BC (2022) editorial policies biomedcentral [Available from: https://www.biomedcentral.com/getpublished/editorial-policies#duplicate+publication

Cited by

See all 23

Metadata

Authors
Lloyd, J. O., Hill, B., Murphy, M., Al-Kaisy, A., Andreou, A. P., & Lambru, G.
Affiliations
  • King's College London (GB)
  • Guy's and St Thomas' NHS Foundation Trust (GB)
Corresponding author
Lambru, G.
Venue
The Journal of Headache and Pain
Published
2022-06-06
Volume
23
Issue
1
Pages
63-63
ISSN
  • 1129-2369 (ISSN-L)
  • 1129-2377
OpenAlex
W4281650061
Cited by
21
References
42
Citations by year
2026: 3 · 2025: 11 · 2024: 2 · 2023: 4 · 2022: 1
FWCI
2.93
Type
journal article
Language
en
Open access
Licence
Locations
  • The Journal of Headache and Pain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
Keywords
single-pulse transcranial magnetic stimulation, migraine prophylaxis, chronic migraine, medication overuse headache, episodic migraine, long-term treatment efficacy, sustained treatment response, headache-related disability, monthly headache days, treatment tolerability, adverse events, real-world evidence, HIT-6, migraine-specific quality of life
MeSH terms
Adult, Headache, Humans, Migraine Disorders, Prospective Studies, Treatment Outcome, Transcranial Magnetic Stimulation, Headache Disorders, Secondary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis. https://app.cochat.ai/papers/10.1186/s10194-022-01428-6
The paper
Lloyd, J. O., Hill, B., Murphy, M., Al-Kaisy, A., Andreou, A. P., & Lambru, G. (2022). Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-022-01428-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.